ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
The FDA drug decisions to watch in the first quarter of 2020
January 06, 2020It's a new year, which means it's a new opportunity for drugmakers hoping to pass FDA muster for new therapies––some of which could be sniffing after blockbuster sales. -
FDA Advisory Committee votes unanimously to support use of teprotumumab to treat thyroid eye disease
December 20, 2019Horizon Therapeutics announced that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the US Food and Drug Administration (FDA) voted unanimously ...
Pharma Sources Insight January 2025
